Register Login
Register to leave comments
  • News bot April 17, 2026, 8:05 p.m.

    🔍 Goin Kathleen (Executive)

    Company: PALVELLA THERAPEUTICS, INC. (PVLA)

    Report Date: 2026-04-15

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 4,302
    • Total shares sold: 8,604

    Detailed Transactions and Holdings:

    • Acquired 2,154 shares of Common Stock at $7.14 per share (Direct)
      Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,154.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 2,148 shares of Common Stock at $9.08 per share (Direct)
      Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,302.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,502 shares of Common Stock at $125.9647 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,800.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,500 shares of Common Stock at $127.1254 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,300.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 561 shares of Common Stock at $128.2349 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 739.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 639 shares of Common Stock at $129.1692 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 100.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 100 shares of Common Stock at $130.33 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,154 shares of Stock Option (Right to Buy) at $7.14 per share (Derivative)
      Date: 2026-04-15 | Code: M | Expires: 2029-10-29 | equity_swap_involved: 0 | shares_owned_after: 12,935.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 2,148 shares of Stock Option (Right to Buy) at $9.08 per share (Derivative)
      Date: 2026-04-15 | Code: M | Expires: 2030-10-14 | equity_swap_involved: 0 | shares_owned_after: 12,888.00 | transaction_form_type: 4 | Footnotes: F1, F6

    Footnotes:

    • F1: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons.
    • F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $125.53 to $126.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
    • F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.77 to $127.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
    • F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.88 to $128.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
    • F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.95 to $129.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
    • F6: The stock option is fully vested.

Search

News categories